These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 7398735)

  • 1. The bioavailability of digoxin from three oral formulations measured by a specific h.p.l.c. assay.
    Cohen AF; Kroon R; Schoemaker HC; Breimer DD; Van Vliet-Verbeek A; Brandenburg HC
    Br J Clin Pharmacol; 1993 Feb; 35(2):136-42. PubMed ID: 8443031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of digoxin and absorption site.
    Magnusson JO; Bergdahl B; Bogentoft C; Jonsson UE
    Br J Clin Pharmacol; 1982 Aug; 14(2):284-5. PubMed ID: 7104181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability of indomethacin from two multiple-units controlled-release formulations.
    Bechgaard H; Brodie RR; Chasseaud LF; Houmøller P; Hunter JO; Siklos P; Taylor T
    Eur J Clin Pharmacol; 1982; 21(6):511-5. PubMed ID: 7075656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of digoxin after oral and intrajejunal administration.
    Magnusson JO
    Br J Clin Pharmacol; 1983 Dec; 16(6):741-2. PubMed ID: 6661363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability of drugs: the digoxin dilemma.
    Greenblatt DJ; Smith TW; Koch-Weser J
    Clin Pharmacokinet; 1976; 1(1):36-51. PubMed ID: 797491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability of digoxin tablets.
    Lindenbaum J
    Pharmacol Rev; 1973 Jun; 25(2):229-37. PubMed ID: 4581042
    [No Abstract]   [Full Text] [Related]  

  • 7. Absorption of digoxin from a new microencapsulated formulation.
    Bergdahl B; Bogentoft C; Jonsson UE; Magnusson JO
    Eur J Clin Pharmacol; 1980 Jun; 17(6):443-7. PubMed ID: 7398735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fasting and postprandial absorption of digoxin from a microencapsulated formulation.
    Bergdahl B; Bogentoft C; Jonsson UE; Magnusson JO
    Eur J Clin Pharmacol; 1983; 25(2):207-10. PubMed ID: 6628502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased metabolism to dihydrodigoxin after intake of a microencapsulated formulation of digoxin.
    Magnusson JO; Bergdahl B; Bogentoft C; Gustafsson S; Jonsson UE
    Eur J Clin Pharmacol; 1984; 27(2):197-202. PubMed ID: 6499898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A completely absorbed oral preparation of digoxin.
    Johnson BF; Bye C; Jones G; Sabey GA
    Clin Pharmacol Ther; 1976 Jun; 19(6):746-51. PubMed ID: 1269214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variability of steady-state digoxin kinetics during administration of tablets or capsules.
    Johnson BF; Lindenbaum J; Budnitz E; Marwaha R
    Clin Pharmacol Ther; 1986 Mar; 39(3):306-12. PubMed ID: 3948469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The comparability of dosage regimens of Lanoxin tablets and Lanoxicaps.
    Johnson BF; Smith G; French J
    Br J Clin Pharmacol; 1977 Apr; 4(2):209-11. PubMed ID: 861135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the in vitro and in vivo release of digoxin from four different soft gelatin capsule formulations.
    Wagner JG; Stoll RG; Weidler DJ; Ayres JW; Hallmark MR; Sakmar E; Yacobi A
    J Pharmacokinet Biopharm; 1979 Apr; 7(2):147-58. PubMed ID: 20218011
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.